0001179110-20-000468.txt : 20200110 0001179110-20-000468.hdr.sgml : 20200110 20200110160500 ACCESSION NUMBER: 0001179110-20-000468 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200109 FILED AS OF DATE: 20200110 DATE AS OF CHANGE: 20200110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTSON MICHELLE CENTRAL INDEX KEY: 0001755098 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 20521105 MAIL ADDRESS: STREET 1: C/O MOMENTA PHARMACEUTICALS, INC. STREET 2: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 edgar.xml FORM 4 - X0306 4 2020-01-09 0 0001650664 Editas Medicine, Inc. EDIT 0001755098 ROBERTSON MICHELLE C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 0 1 0 0 Chief Financial Officer Common Stock 2020-01-09 4 A 0 20000 0 A 20000 D Stock Option (right to buy) 30.65 2020-01-09 4 A 0 120000 0 A 2030-01-08 Common Stock 120000 120000 D The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on January 9, 2021 continuing through January 9, 2024. This option was granted on January 9, 2020 and is scheduled to vest over four years, with 25% of the shares to vest on January 9, 2021 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through January 9, 2024. /s/ Michelle Robertson 2020-01-10